SEARCH

SEARCH BY CITATION

References

  • 1
    Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993; 35: 219226.
  • 2
    Dickinson JP & Prentice CRM. Aspirin: benefit and risk in thromboprophylaxis. Quart J Med 1998; 91: 523538.
  • 3
    Stalnikowicz-Darvasi R. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. J Clin Gastroenterol 1995; 21: 1316.
  • 4
    Slattery J, Warlow CP, Shorrock CJ, Langman MJS. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin – analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995; 37: 509511.
  • 5
    Derry S & Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. Br Med J 2000; 321: 11831187.
  • 6
    Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 115: p 787796.
  • 7
    Bollini P, Garcı´a Rodrı´guez LA, Pérez Gutthann S, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med 1992; 152: 12891295.
  • 8
    Henry D, Lim LL, Garcı´a Rodrı´guez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996; 312: 15631566.
  • 9
    Hotiezer JW, Silvoso GR, Burks M, Ivey KJ. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; ii: 609612.
  • 10
    Lanza FL, Royer GL, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 304: 136137.
  • 11
    Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage. prevention by enteric coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991; 32: 7783.
  • 12
    Petroski D. Endoscopic comparison of three aspirin preparations and placebo. Clin Ther 1993; 15: 1993.
  • 13
    Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257263.
  • 14
    Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models. Am J Med 1991; 91: 213222.
  • 15
    García Rodríguez LA, Walker AM, Perez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a Cohort Study. Epidemiology 1992; 3: 337342.
  • 16
    Voskuyl AE, Van de Laar MAFJ, Moens HJB, Van der Korst JK. Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events. Ann Rheum Dis 1993; 53: 771775.
  • 17
    Lanas A. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862869.
  • 18
    Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153: 16651670.
  • 19
    Marriott JF, Asquith PA, Shorrock CJ. The use of proprietary medicines by patients presenting with peptic ulcer haemorrhage. Br J Clin Pharmacol 1993; 35: 451455.
  • 20
    Garcı´a Rodrı´guez LA & Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769772.
  • 21
    Lanza LL, Walker AM, Bortnichack EA, Dreyer NA. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study. Arch Intern Med 1995; 155: 13711377.
  • 22
    Traversa G, Walker AM, Ippolito FM, et al. Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 1995; 6: 4954.
  • 23
    Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995; 141: 539545.
  • 24
    Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90: 206210.
  • 25
    Cullen D, Hawkey G, Greenwood D, et al. Peptic ulcer bleeding in the elderly. relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997; 41: 459462.
  • 26
    MacDonald T, Morant S, Robinson G, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. Br Med J 1997; 315: 13331337.
  • 27
    Kurata J, Nogawa A, Noritake D. NSAIDs increase risk of gastrointestinal bleeding in primary care patients with dyspepsia. J Family Prac 1997; 45: 227235.
  • 28
    Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997; 112: 683689.
  • 29
    Menniti-Ippolito F, Maggini M, Raschetti R, Da Cas R, Traversa G, Walker AM. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol 1998; 54: 393397.
  • 30
    Singh G & Ramey DR. NSAID induced gastrointestinal complications. The ARAMIS Perspective −1997. J Rheumatol 1998; 25(Suppl. 51): 816.
  • 31
    Singh G & Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999; 26(Suppl. 26): 1824.
  • 32
    Weil J, Langman M, Wainwright P, et al. Peptic ulcer bleeding, accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000; 46: 2731.
  • 33
    Hansen JM, Hallas J, Lauritsen JM, Bytzer P. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol 1996; 31: 126130.
  • 34
    Peura DA, Lanza FL, Gostout CJ, Foutch PG. The American College of Gastroenterology Bleeding Registry: Preliminary findings. Am J Gastroenterol 1997; 92: 924928.
  • 35
    Blot WJ & McLaughlin JK. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding. J Epidemiol Biostatistics 2000; 5: 137142.
  • 36
    Chan T, Critchley J, Lau J, Sung J, Chung S, Anderson D. The relationship between upper gastrointestinal hemorrhage and drug use: a case control study. Int J Clin Pharmacol Ther 1996; 34: 304308.
  • 37
    Nobili A & Mosconi P. Emorragie del tratto gastroenterico superiore e farmaci anti-infiammatori non steroidei: risultati de una sorvegglianza caso-controllo. Recenti Progressi Med 1993; 84: 126.
  • 38
    Nobili A, Mosconi P, Franzosi MG, Tognoni G. Non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding, a post-marketing surveillance case-control study. Pharmacoepidemiology Drug Safety 1992; 1: 6572.
  • 39
    Langman M, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 342: 10751078.
  • 40
    Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485494.
  • 41
    Lanas A, Bajador E, Serrano P, Arroyo M, Fuentes J, Santolaria S. Effects of nitrate and prophylactic aspirin on upper gastrointestinal bleeding: a retrospective case-control study. J Int Med Res 1998; 26: 120128.
  • 42
    Kaufman DW, Kelly JP, Wiholm B-E, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol 1999; 94: 31893196.
    Direct Link:
  • 43
    Laporte J-R, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal antiinflammatory drugs. Lancet 1991; 337: 8589.
  • 44
    Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete M. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991; 32: 730734.
  • 45
    Keating J. Antiinflammatory drugs and emergency surgery for peptic ulcers in the Waikato. N Z Med J 1992; 105: 127129.
  • 46
    Henry D, Dobson A, Truner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology1993; 105: 10781088.
  • 47
    Savage R, Moller P, Ballantyne C, Wells J. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheumatism 1993; 36: 8490.
  • 48
    Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827830.
  • 49
    Hallas J, Lauritsen J, Dalsgard Villadsen H, Freng Gram L. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30: 438444.
  • 50
    Matikaienen M & Kangas E. Is there a relationship between the use of analgesics and non-steroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding? A Finnish case-control prospective study. Scand J Gastroenterol 1996; 31: 912916.
  • 51
    Kelly JP, Kaufman DW, Jugelon JM, Sheehan JE, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 14141416.
  • 52
    McMahon A, Evans J, White G, et al. A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation. J Clin Epidemiol 1997; 50: 351356.DOI: 10.1016/s0895-4356(96)00361-7
  • 53
    Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997; 42: 990997.
  • 54
    Pérez-Gutthann S, Garcia Rodriguez LA, Raiford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997; 8: 1824.
  • 55
    García Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998; 158: 3339.
  • 56
    Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000; 343: 834839.
  • 57
    Sorensen HT, Mellemkjaer L, Blot WJ, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000; 95: 22182224.
  • 58
    De Abajo FJ & Garcia Rodriguez LA. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol 2001; 1: 1.
  • 59
    Jick H, Garcia Rodriguez LA, Perez-Guthann S. Principles of epidemiological research on adverse and beneficial drug effects. Lancet 1998; 352: 17671770.DOI: 10.1016/s0140-6736(98)04350-5
  • 60
    Takkouche B, Cadarso-Suarez C, Spiegelman D. An evaluation of old and new tests of heterogeneity in meta-analysis in epidemiologic research. Am J Epidemiol 1999; 150: 206215.
  • 61
    Poole C & Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol 1999; 150: 469475.
  • 62
    DerSimonian R & Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 77188.
  • 63
    Walker AM. Observation and inference. An introduction to the methods of epidemiology. Newton Lower Falls: Epidemiology Resources Inc., 1991.
  • 64
    Cooper H & Hedges LV. The handbook of research synthesis. New York: Russel Sage Foundation, 1994.
  • 65
    Patrono C.. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 12871294.
  • 66
    Hawkey C. Review article: aspirin and gastrointestinal bleeding. Alimentary Pharmacol Ther 1994; 8: 141146.
  • 67
    Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 18881899.
  • 68
    Physicians' Desk Reference. 53 edition, Montrale, NJ. Medical Economics Company, 1999.
  • 69
    Olivero J & Graham D. Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol 1992; 27(Suppl. 193): 5358.
  • 70
    Shapiro S. Point/Counterpoint: Meta-analysis of observational studies. Am J Epidemiol 1994; 140: 771778.
  • 71
    Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996; 25: 11071116.
  • 72
    Drews CD & Greenland S. The impact of differential recall on the results of case-control studies. Int J Epidemiol 1990; 19: 11071112.
  • 73
    Ulcickas YM, Rothman K, Johnson C, et al. Using prescription claims for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Safety 2000; 9: S37.